Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of pyrrolopyrimidines. It has the chemical formula C11H15N4O7P and a molecular weight of approximately 346.23 g/mol. The structure features a pyrrolopyrimidine moiety linked to a substituted pyrrolidine ring with dihydrogen phosphate as an ester group. There is no evidence that this compound has been approved for any medical use or advanced beyond experimental status; it does not have known clinical indications or established mechanism of action in humans. Its primary relevance appears to be as an experimental or research chemical rather than as a developed pharmaceutical agent[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate.